Evidence map›Paper›PMID 30900502›Full record

ReviewRNA biology2019

Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.

Rengen Fan, Chaocheng Xiao, Xinqiang Wan, Wenzhang Cha, Yufeng Miao, Yong Zhou, Chenglin Qin, Ting Cui, Fenglian Su, Xiangxiang Shan

Open access · bronzeAbstract readReview
In one paragraph

Review in RNA biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. The Role of miR-138 in Cardiovascular Diseases.BioMed research international · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. The MicroRNAs in the Pathophysiology of Osteoporosis.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Alkyne Activation in the Diversity Oriented Synthesis of spChemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rengen Fana Department of General Surgery, Yancheng City No. 1 People's Hospital , Yancheng , China.
Chaocheng Xiaob Department of General Surgery, Yancheng City No. 1 People's Hospital , Yancheng , China.
Xinqiang Wanc Department of Gynaecology and Obstetrics, Yancheng City No. 1 People's Hospital , Yancheng , China.
Wenzhang Chaa Department of General Surgery, Yancheng City No. 1 People's Hospital , Yancheng , China.
Yufeng Miaod Department of Medical Oncology , Wuxi Third People's Hospital , Wuxi , China.
Yong Zhoua Department of General Surgery, Yancheng City No. 1 People's Hospital , Yancheng , China.
Chenglin Qina Department of General Surgery, Yancheng City No. 1 People's Hospital , Yancheng , China.
Ting Cuie Department of Cardiology, The Third People's Hospital of Yancheng , Yancheng , China.
Fenglian Suf School of Medical University, Xuzhou , Xuzhou , China.
Xiangxiang Shang Department of Geraeology, Yancheng City No.1 People's Hospital , Yancheng , China.
Nantong University · CNWuxi Third People's Hospital · CNXuzhou Medical College · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that post-transcriptionally regulate gene expression. Aberrant miRNA expression or function have close links with various human diseases. Therefore, therapeutic treatments with disease-associated miRNAs as targets are emerging. However, the intracellular miRNA networks are extremely complicated and poorly understood, which thus hinder the development of miRNA-targeted therapeutics. Small molecules that are able to regulate endogenous miRNAs hold great potential in both elucidation of miRNA networks and treatment of miRNA-related diseases. Herein, we summarize current strategies for discovery of small molecule modifiers of miRNAs, and we highlight aspects of miRNA cellular biology elucidated by using these small molecules and miRNA-targeted therapeutics realized by these small molecules. We envision that this area will expand dramatically in the near future and will ultimately contribute to a better understanding of miRNA-involved cellular processes and development of therapeutic agents for miRNA-associated diseases.

Indexed as

Drug TherapyComputational BiologyDiseaseHumansMicroRNAsNucleic Acid ConformationMicroRNAsMicrornamicroRNA networksmall moleculetherapeutics

Identifiers

PMID30900502
PMCPMC6546413
OpenAlexW2924908935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.